Chemicals that decrease the expression levels of significant TWAS genes negatively associated with UF. by Gayeon Kim (671557)

Glucose disposal rate (GDR) is significantly decreased in P HFHS dams. by Akansha Mishra (2632600)

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the two groups WAD grades 2 and 3. by Anneli Peolsson (7867601)

Subjects:

GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

“…<p>(A) COA3 and COA6 (1.5 × 10³) cells were treated with increasing concentrations of GSK343 (0, 5, 15, 25 μM) for 24 hours and viability was measured with alamarBlue^® assay. GSK343 treatment resulted in significantly decreased viability. (B) COA3 and COA6 (1.5 × 10³) cells were treated with increasing concentrations of GSK343 (0, 5, 15, 25 μM) for 24 hours and proliferation was measured using CellTiter^® assay. …”

STORMS microbiome reporting checklist. by Katrine Carlsen (5477300)

“…</p><p>A significant decrease over time in Shannon diversity, following the initial increase within four weeks of treatment, was found across patients. …”

Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

Stratified results for parental stressors. by Ragnhild Bjørknes (4908577)

Subjects:

GTDE restored recognition memory against d-gal induced aging. by Hui-Chuan Kuo (12368492)

Subjects:

GTDE effectively reduced d-gal-induced oxidative stress and increased the expression levels of antioxidant proteins and BDNF. by Hui-Chuan Kuo (12368492)

Subjects:

The application of GTDE efficiently increased the D-gal induced decline in the expression levels of BDNE. by Hui-Chuan Kuo (12368492)

Subjects:

Image_2_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_1_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_3_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_14_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_13_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_4_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Presentation_1_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.pdf by Rohit Moudgil (540119)

Image_11_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

Image_4_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_7_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)